Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2024)

Solid Biosciences' Interest & Investment Income history spans 8 years, with the latest figure at $1.9 million for Q4 2024.

  • For Q4 2024, Interest & Investment Income rose 9.38% year-over-year to $1.9 million; the TTM value through Dec 2024 reached $9.5 million, up 24.89%, while the annual FY2024 figure was $9.5 million, 24.89% up from the prior year.
  • Interest & Investment Income for Q4 2024 was $1.9 million at Solid Biosciences, down from $2.3 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.7 million in Q1 2024 and bottomed at -$20000.0 in Q3 2020.
  • The 5-year median for Interest & Investment Income is $1.1 million (2022), against an average of $1.1 million.
  • The largest annual shift saw Interest & Investment Income crashed 108.54% in 2021 before it surged 3231.48% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at -$16000.0 in 2020, then increased by 18.75% to -$13000.0 in 2021, then surged by 11900.0% to $1.5 million in 2022, then increased by 14.73% to $1.8 million in 2023, then grew by 9.38% to $1.9 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Interest & Investment Income are $1.9 million (Q4 2024), $2.3 million (Q3 2024), and $2.6 million (Q2 2024).